Home » Life & Medical » Research on Myotonic Dystrophy Drug Market 2016-2020 and Forecast 2021-2026

Research on Myotonic Dystrophy Drug Market 2016-2020 and Forecast 2021-2026

  89 Pages     Life & Medical  

Available Formats      

Report ID: 68890
Published By: 99Strategy

Summary

The Global Myotonic Dystrophy Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Myotonic Dystrophy Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

ISIS-DMPKRx 

PRO-135 

SRT-152 

VAL-0411 

Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

BioMarin Pharmaceutical Inc. 

F. Hoffmann-La Roche Ltd. 

Genzyme Corporation 

Isis Pharmaceuticals, Inc. 

Marina Biotech, Inc. 

Valentia Biopharma S.L

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital 

Clinic 

Home Use 

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Industry Overview

1.1 Myotonic Dystrophy Drug Industry

Figure Myotonic Dystrophy Drug Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Myotonic Dystrophy Drug

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Myotonic Dystrophy Drug

1.2.2 Downstream

Table Application Segment of Myotonic Dystrophy Drug

Table Global Myotonic Dystrophy Drug Market 2016-2026, by Application, in USD Million

1.2.3 COVID-19 Impact

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Myotonic Dystrophy Drug Market by Type

3.1 By Type

3.1.1 ISIS-DMPKRx 

Table Major Company List of ISIS-DMPKRx 

3.1.2 PRO-135 

Table Major Company List of PRO-135 

3.1.3 SRT-152 

Table Major Company List of SRT-152 

3.1.4 VAL-0411 

Table Major Company List of VAL-0411 

3.1.5 Others

Table Major Company List of Others

3.2 Market Size

Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in USD Million

Figure Global Myotonic Dystrophy Drug Market Growth 2016-2020, by Type, in USD Million

Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in Volume

Figure Global Myotonic Dystrophy Drug Market Growth 2016-2020, by Type, in Volume

3.3 Market Forecast

Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in USD Million

Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in Volume

4 Major Companies List

4.1 BioMarin Pharmaceutical Inc.  (Company Profile, Sales Data etc.)

4.1.1 BioMarin Pharmaceutical Inc.  Profile

Table BioMarin Pharmaceutical Inc.  Overview List

4.1.2 BioMarin Pharmaceutical Inc.  Products & Services

4.1.3 BioMarin Pharmaceutical Inc.  Business Operation Conditions

Table Business Operation of BioMarin Pharmaceutical Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 F. Hoffmann-La Roche Ltd.  (Company Profile, Sales Data etc.)

4.2.1 F. Hoffmann-La Roche Ltd.  Profile

Table F. Hoffmann-La Roche Ltd.  Overview List

4.2.2 F. Hoffmann-La Roche Ltd.  Products & Services

4.2.3 F. Hoffmann-La Roche Ltd.  Business Operation Conditions

Table Business Operation of F. Hoffmann-La Roche Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Genzyme Corporation  (Company Profile, Sales Data etc.)

4.3.1 Genzyme Corporation  Profile

Table Genzyme Corporation  Overview List

4.3.2 Genzyme Corporation  Products & Services

4.3.3 Genzyme Corporation  Business Operation Conditions

Table Business Operation of Genzyme Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Isis Pharmaceuticals, Inc.  (Company Profile, Sales Data etc.)

4.4.1 Isis Pharmaceuticals, Inc.  Profile

Table Isis Pharmaceuticals, Inc.  Overview List

4.4.2 Isis Pharmaceuticals, Inc.  Products & Services

4.4.3 Isis Pharmaceuticals, Inc.  Business Operation Conditions

Table Business Operation of Isis Pharmaceuticals, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Marina Biotech, Inc.  (Company Profile, Sales Data etc.)

4.5.1 Marina Biotech, Inc.  Profile

Table Marina Biotech, Inc.  Overview List

4.5.2 Marina Biotech, Inc.  Products & Services

4.5.3 Marina Biotech, Inc.  Business Operation Conditions

Table Business Operation of Marina Biotech, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Valentia Biopharma S.L (Company Profile, Sales Data etc.)

4.6.1 Valentia Biopharma S.L Profile

Table Valentia Biopharma S.L Overview List

4.6.2 Valentia Biopharma S.L Products & Services

4.6.3 Valentia Biopharma S.L Business Operation Conditions

Table Business Operation of Valentia Biopharma S.L (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Myotonic Dystrophy Drug Sales Revenue 2016-2020, by Company, in USD Million

Table Global Myotonic Dystrophy Drug Sales Revenue Share 2016-2020, by Company, in USD Million

Figure Global Myotonic Dystrophy Drug Sales Revenue Share in 2020, by Company, in USD Million

Table Global Myotonic Dystrophy Drug Sales Volume 2016-2020, by Company, in Volume

Table Global Myotonic Dystrophy Drug Sales Volume Share 2016-2020, by Company, in Volume

Figure Global Myotonic Dystrophy Drug Sales Volume Share in 2020, by Company, in Volume

5.2 Regional Market by Company

Figure North America Myotonic Dystrophy Drug Market Concentration, in 2020

Figure Europe Myotonic Dystrophy Drug Market Market Concentration, in 2020

Figure Asia-Pacific Myotonic Dystrophy Drug MMarket Concentration, in 2020

Figure South America Myotonic Dystrophy Drug Market Concentration, in 2020

Figure Middle East & Africa Myotonic Dystrophy Drug Market Concentration, in 2020

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital 

Figure Myotonic Dystrophy Drug Demand in Hospital , 2016-2020, in USD Million

Figure Myotonic Dystrophy Drug Demand in Hospital , 2016-2020, in Volume

6.1.2 Demand in Clinic 

Figure Myotonic Dystrophy Drug Demand in Clinic , 2016-2020, in USD Million

Figure Myotonic Dystrophy Drug Demand in Clinic , 2016-2020, in Volume

6.1.3 Demand in Home Use 

Figure Myotonic Dystrophy Drug Demand in Home Use , 2016-2020, in USD Million

Figure Myotonic Dystrophy Drug Demand in Home Use , 2016-2020, in Volume

6.1.4 Demand in Others

Figure Myotonic Dystrophy Drug Demand in Others, 2016-2020, in USD Million

Figure Myotonic Dystrophy Drug Demand in Others, 2016-2020, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in USD Million

Figure Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in USD Million

Figure Myotonic Dystrophy Drug Market Share in 2026, by Application, in USD Million

Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in Volume

Table Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in Volume

Table Myotonic Dystrophy Drug Market Share in 2026, by Application, in Volume

6.4 Impact of the COVID-19 on the Demand

7 Region Operation

7.1 Regional Production

Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in USD Million

Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in Volume

7.2 Regional Market

Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in USD Million

Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in USD Million

Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in Volume

Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

Figure North America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

Figure Europe Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

Figure South America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

Figure Middle East & Africa Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in USD Million

Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

1. Table Upstream Segment of Myotonic Dystrophy Drug

2. Table Application Segment of Myotonic Dystrophy Drug

3. Table Global Myotonic Dystrophy Drug Market 2016-2026, by Application, in USD Million

4. Table Major Company List of PRO-135 

5. Table Major Company List of SRT-152 

6. Table Major Company List of VAL-0411 

7. Table Major Company List of Others

8. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in USD Million

9. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Type, in Volume

10. Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in USD Million

11. Table Global Myotonic Dystrophy Drug Market Forecast 2021-2026, by Type, in Volume

12. Table BioMarin Pharmaceutical Inc.  Overview List

13. Table Business Operation of BioMarin Pharmaceutical Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

14. Table F. Hoffmann-La Roche Ltd.  Overview List

15. Table Business Operation of F. Hoffmann-La Roche Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

16. Table Genzyme Corporation  Overview List

17. Table Business Operation of Genzyme Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

18. Table Isis Pharmaceuticals, Inc.  Overview List

19. Table Business Operation of Isis Pharmaceuticals, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

20. Table Marina Biotech, Inc.  Overview List

21. Table Business Operation of Marina Biotech, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

22. Table Valentia Biopharma S.L Overview List

23. Table Business Operation of Valentia Biopharma S.L (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

24. Table Global Myotonic Dystrophy Drug Sales Revenue 2016-2020, by Company, in USD Million

25. Table Global Myotonic Dystrophy Drug Sales Revenue Share 2016-2020, by Company, in USD Million

26. Table Global Myotonic Dystrophy Drug Sales Volume 2016-2020, by Company, in Volume

27. Table Global Myotonic Dystrophy Drug Sales Volume Share 2016-2020, by Company, in Volume

28. Table Regional Demand Comparison List

29. Table Major Application in Different Regions

30. Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in USD Million

31. Table Myotonic Dystrophy Drug Demand Forecast 2021-2026, by Application, in Volume

32. Table Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in Volume

33. Table Myotonic Dystrophy Drug Market Share in 2026, by Application, in Volume

34. Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in USD Million

35. Table Myotonic Dystrophy Drug Production 2016-2020, by Region, in Volume

36. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in USD Million

37. Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in USD Million

38. Table Global Myotonic Dystrophy Drug Market 2016-2020, by Region, in Volume

39. Table Global Myotonic Dystrophy Drug Market Share 2016-2020, by Region, in Volume

40. Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

41. Table North America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

42. Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

43. Table Europe Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

44. Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

45. Table Asia-Pacific Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

46. Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

47. Table South America Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

48. Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in USD Million

49. Table Middle East & Africa Myotonic Dystrophy Drug Market Size 2016-2020, by Country, in Volume

50. Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in USD Million

51. Table Myotonic Dystrophy Drug Market Forecast 2021-2026, by Region, in Volume

52. Table Price Factors List

List of Figure

1. Figure Myotonic Dystrophy Drug Industry Chain Structure

2. Figure Global Myotonic Dystrophy Drug Market Growth 2016-2020, by Type, in USD Million

3. Figure Global Myotonic Dystrophy Drug Market Growth 2016-2020, by Type, in Volume

4. Figure Global Myotonic Dystrophy Drug Sales Revenue Share in 2020, by Company, in USD Million

5. Figure Global Myotonic Dystrophy Drug Sales Volume Share in 2020, by Company, in Volume

6. Figure North America Myotonic Dystrophy Drug Market Concentration, in 2020

7. Figure Europe Myotonic Dystrophy Drug Market Market Concentration, in 2020

8. Figure Asia-Pacific Myotonic Dystrophy Drug MMarket Concentration, in 2020

9. Figure South America Myotonic Dystrophy Drug Market Concentration, in 2020

10. Figure Middle East & Africa Myotonic Dystrophy Drug Market Concentration, in 2020

11. Figure Myotonic Dystrophy Drug Demand in Hospital , 2016-2020, in USD Million

12. Figure Myotonic Dystrophy Drug Demand in Hospital , 2016-2020, in Volume

13. Figure Myotonic Dystrophy Drug Demand in Clinic , 2016-2020, in USD Million

14. Figure Myotonic Dystrophy Drug Demand in Clinic , 2016-2020, in Volume

15. Figure Myotonic Dystrophy Drug Demand in Home Use , 2016-2020, in USD Million

16. Figure Myotonic Dystrophy Drug Demand in Home Use , 2016-2020, in Volume

17. Figure Myotonic Dystrophy Drug Demand in Others, 2016-2020, in USD Million

18. Figure Myotonic Dystrophy Drug Demand in Others, 2016-2020, in Volume

19. Figure Myotonic Dystrophy Drug Market Growth 2021-2026, by Application, in USD Million

20. Figure Myotonic Dystrophy Drug Market Share in 2026, by Application, in USD Million

21. Figure North America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

22. Figure North America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

23. Figure Europe Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

24. Figure Europe Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

25. Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

26. Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

27. Figure South America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

28. Figure South America Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

29. Figure Middle East & Africa Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in USD Million

30. Figure Middle East & Africa Myotonic Dystrophy Drug Market Size and Growth 2016-2020, in Volume

31. Figure Marketing Channels Overview

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020